Erin Hunter is a Weekend Anchor and Reporter for Pharmacy Times. With a background in journalism and a focus on healthcare and medical research, Erin's articles provide valuable insights into the latest developments in the pharmaceutical industry. Her work has also been featured in KLST News, WFAA, and AJMC - The American Journal of Managed Care.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Erin Hunter's articles predominantly focus on medical research, patient outcomes, treatment options, and disease management. Based on her coverage attributes, she appears to value data-driven insights with a significant portion of her content citing data. Erin may be open to pitches from experts who can provide commentary or analysis based on scientific evidence and clinical trials in the healthcare and pharmaceutical sectors.
Sources with access to relevant research findings or those involved in conducting clinical trials could capture Erin's attention. Additionally, professionals specializing in patient outcomes and treatment options within the healthcare sector might find success when reaching out to Erin for potential collaboration opportunities.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Erin Hunter
This treatment improved the severity of symptoms in patients with scalp and nail psoriasis.
Women who have longer ovarian function and enter menopause later in life tend to live longer, according to women's health researcher.
Compared to placebo, risankizumab significantly reduced symptom severity for patients with moderate to severe disease.
By: Erin Hunter
Their expansive scope of services can ultimately help to elevate the work of the entire community pharmacy.
By: Erin Hunter
The FDA-approved topical and oral agent is currently indicated for adult patients with patterned alopecia.
Pharmacists at this clinic work with patients to improve medication education, affordability, and access to care.
By: Erin Hunter
A lack of equity in clinical research has direct impacts on patient care and outcomes
By: Erin Hunter
PT886 (Phanes Therapeutics) received fast track designation 2 years after receiving orphan drug designation by the FDA.
Melatonin is linked to circadian rhythm, mitochondrial function, and neuroinflammation.
Evidence suggests foods that activate sirtuin proteins may be beneficial for metabolic syndromes
(833) 317-6278 
